SCHEMBL20409266

SCHEMBL20409266

CC(C)c1ccc2c(O)coc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPA1 O75762 1/20 0.46
▸ PTGS1 P23219 1/20 0.46
▸ CACNA1C Q13936 1/20 0.46
▸ ALDH1A1 P00352 3/20 0.44
▸ HTT P42858 3/20 0.44
▸ ALOX12 P18054 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ PTPN1 P18031 1/20 0.43
▸ RNASEH1 O60930 1/20 0.42
▸ TYR P14679 3/20 0.41
▸ MAPT P10636 4/20 0.38
▸ TP53 P04637 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MDM4 O15151 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17615540 0.79 PTPN1 (0.47) TRPA1PTGS1CACNA1CALDH1A1HTT
SCHEMBL10216166 0.79 PTPN1 (0.44) TRPA1PTGS1CACNA1CALDH1A1HTT
SCHEMBL23478524 0.78 ALDH1A1 (0.44) TRPA1PTGS1CACNA1CALDH1A1HTT
SCHEMBL22672437 0.76 TBK1 (0.48) GAAPTPN1MAPTKDM4EALOX15
SCHEMBL4247045 0.74 KDM4E (0.54) ALDH1A1HTTGAAMAPTTP53
SCHEMBL29972769 0.74 KDM4E (0.54) ALDH1A1HTTGAAMAPTTP53
SCHEMBL22185375 0.73 PIN1 (0.59) PTGS1ALDH1A1HTTGAAHIF1A
SCHEMBL28238868 0.71 PTPN1 (0.48) TRPA1PTGS1CACNA1CALDH1A1HTT
SCHEMBL2706167 0.71 BCHE (0.45) TRPA1PTGS1CACNA1CALDH1A1HTT
SCHEMBL4416630 0.70 ALOX15 (0.37) ALDH1A1ALOX12PTPN1TYRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208602-A1 NEW BICYCLIC COMPOUNDS AS ATX INHIBITORS HOFFMANN-LA ROCHE INC. (US) 2018-07-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180208602-A1 NEW BICYCLIC COMPOUNDS AS ATX INHIBITORS ATXN2, ATXN10, ATXN2L TRPA1 3695/4885PTGS1 3520/4885CACNA1C 1038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback